Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinoma

Recent advances in molecular subtyping of Pancreatic Ductal Adenocarcinoma (PDAC) support individualization of therapeutic strategies in this most aggressive disease. With the emergence of various novel therapeutic strategies and neoadjuvant approaches in this quickly deteriorating disease, robust a...

Descripción completa

Detalles Bibliográficos
Autores principales: Trajkovic-Arsic, M., Heid, I., Steiger, K., Gupta, A., Fingerle, A., Wörner, C., Teichmann, N., Sengkwawoh-Lueong, S., Wenzel, P., Beer, A. J., Esposito, I., Braren, R., Siveke, J. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719052/
https://www.ncbi.nlm.nih.gov/pubmed/29213099
http://dx.doi.org/10.1038/s41598-017-16826-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719052/
https://www.ncbi.nlm.nih.gov/pubmed/29213099
http://dx.doi.org/10.1038/s41598-017-16826-z

Ejemplares similares